Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / I•• E•••••••••

V•••••• Acquires I•• E•••••••••, Enhancing Pharmacovigilance and Compliance Capabilities

Add-on acquisitionclosedadd-onannounced May 31, 2024closed Jun 3, 2024Fact
What happened
Target
I•• E•••••••••
Platform
V••••••add-on basis: V•••••• Acquires I•• E•••••••••, Enhancing Pharmacovigilance and Compliance Capabilities | V•••••• is held by L•••••••• Capital on its portfolio page; published on L•••••••• Capital's own news page
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • V••••••Platformconfirmed
    “V•••••• Acquires I•• E•••••••••, Enhancing Pharmacovigilance and Compliance Capabilities | V•••••• is held by L•••••••• Capital on its portfolio page; published on L•••••••• Capital's own news page”
  • L•••••••• C••••••• L••Sponsorconfirmed
    “V•••••• Acquires I•• E•••••••••, Enhancing Pharmacovigilance and Compliance Capabilities | V•••••• is held by L•••••••• Capital on its portfolio page; published on L•••••••• Capital's own news page”
Side not stated
  • B•••• G•••••••••Managementconfirmed
    ““The I•• E••••••••• team shares V••••••’s mission of trust and ultimately improving the quality of life for patients,” says B•••• G•••••••••, the co-founder of I•• E•••••••••, who will join the V•••••• leadership team.”
  • I•• E•••••••••Targetconfirmed
    “V•••••• Acquires I•• E•••••••••, Enhancing Pharmacovigilance and Compliance Capabilities”
Evidence
“V•••••• Acquires I•• E•••••••••, Enhancing Pharmacovigilance and Compliance Capabilities”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026